References
American Heart Association. Heart disease and stroke statistics- 2005 update. Available at: http://www.americanheart.org/ downloadable/heart/1105390918119HDSStats2005Update.pdf. Accessed April 1, 2005.
National Health Service-National Institute for Clinical Excellence, Technology Appraisal Consultation Document: myocardial perfusion scintigraphy for the diagnosis and management of CAD. Available from: URL: http://www.nice.org.uk/article.asp?a± 80521. Accessed August 15, 2003.
Mark DB, Hlatky MA. Medical economics and the assessment of value in cardiovascular medicine: part I. Circulation 2002;106:516–20.
Mark DB, Shaw LJ, Lauer MS, O’Malley P, Heidenreich P. 34th Bethesda Conference: task force #5—is atherosclerotic imaging cost effective? From the 34th Bethesda Conference on Atherosclerotic Imaging. J Am Coll Cardiol 2003;41:1906–17.
Mowatt G, Vale L, Brazzelli M, Hernandez R, Murray A, Scott N, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Available at: http://www.hta.nhsweb.nhs.uk. Accessed April 1, 2005. Health Technol Assess 2004;8:1–222.
Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers F, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004;25:1940–65.
Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint J, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. A consensus conference organised by the British Cardiac Society, the British Nuclear Cardiology Society and the British Nuclear Medicine Society, endorsed by the Royal College of Physicians of London and the Royal College of Radiologists. Eur J Nucl Med Mol Imaging 2004;31:261–91.
Shaw LJ, Iskandrian AE. Prognostic value of stress gated SPECT in patients with known or suspected coronary artery disease. J Nucl Cardiol 2004;11:171–85.
Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American Society of Nuclear Cardiology. ACC/AHA/ASNC guidelines for fication of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 2004;43:200–8.
Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman JD, Shaw LJ. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002;105:823–9.
Mattera JA, Arain SA, Sinusas AJ, Finta L, Wackers FJ. Exercise testing with myocardial perfusion imaging in patients with normal baseline electrocardiograms: cost savings with a stepwise diagnostic strategy. J Nucl Cardiol 1998;5:498–506.
Underwood SR, Godman B, Salvani S, Ogle JR, Ell PJ. Economics of myocardial perfusion imaging in Europe—the EMPIRE study. Eur Heart J 1999;20:157–66.
Marwick TH, Shaw LJ, Case C, Vasey ??, Thomas JD. Clinical and economic impact of exercise electrocardiography and exercise echocardiography in clinical practice. Eur Heart J 2003;24:1153- 63.
Jacklin PB, Barrington SF, Roxburgh JC, Jackson G, Sariklis D, West PA, et al. Cost-effectiveness of preoperative positron emission tomography in ischemic heart disease. Ann Thorac Surg 2002;73:1403–9.
Agency for Healthcare Research and Quality. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Summary; evidence report/technology assessment: Number 80. AHRQ. Publication No. 03-E034. Available at: www.ahrq/gov/clinic/epcsums/chdwomsum.htm. Accessed June 15, 2004.
Lee DS, Jang MJ, Cheon GJ, Chung J-K, Lee CL. Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results. J Nucl Cardiol 2002;9:515–22.
Pryor DB, Shaw L, McCants CB, Lee KL, Mark DB, Harrell FE Jr, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993; 118:81–90.
Heller GV, Stowers SA, Hendel RC, Herman SD, Daher E, Ahlberg AW, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998;31:1011–7.
Udelson JE, Beshansky JR, Ballin DS, Feldman JA, Griffith JL, Handler J, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA 2002;288:2693–700.
Weissman IA, Dickinson CZ, Dworkin HJ, O’Neill WW, Juni JE. Cost-effectiveness of myocardial perfusion imaging with SPECT in the emergency department evaluation of patients with unexplained chest pain. Radiology 1996;199:353–7.
Kontos MC, Schmidt KL, McCue M, Rossiter LF, Jurgensen M, Nicholson CS, et al. A comprehensive strategy for the evaluation and triage of the chest pain patient: a cost comparison study. J Nucl Cardiol 2003;10:284–90.
Knott JC, Baldey AC, Grigg LE, Cameron PA, Lichtenstein M, Better N. Impact of acute chest pain Tc-99m sestamibi myocardial perfusion imaging on clinical management. J Nucl Cardiol 2002; 9:257–62.
Radensky PW, Hilton TC, Fulmer H, McLaughlin BA, Stowers SA. Potential cost-effectiveness of initial myocardial perfusion imaging for assessment of emergency department patients with chest pain. Am J Cardiol 1997;79:595–9.
Stowers SA, Eisenstein EL, Wackers FJ, Berman DS, Blackshear JL, Jones ADJ, et al. An economic analysis of an aggressive diagnostic strategy with single photon emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but nondiagnostic electrocardiograms: results from a randomized trial. Ann Emerg Med 2000;35:17–25.
Kosnik JW, Zalenski RJ, Grzybowski M, Huang R, Sweeny PJ, Welch RD. Impact of technetium-99m sestamibi imaging on the emergency department management and costs in the evaluation of low-risk chest pain. Acad Emerg Med 2001;8:315–23.
Abbott BG, Abdel-Aziz I, Nagula S, Monico EP, Schriver JA, Wackers FJ. Selective use of single-photon emission computed tomography myocardial perfusion imaging in a chest pain center. Am J Cardiol 2001;87:1351–5.
Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32–40.
Shaw LJ, Heller GV, Travin MI, Lauer M, Marwick T, Hachamovitch R, et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol 2002;9:515–22.
Fineberg HV, Scadden D, Goldman L. Care of patients with a low probability of acute myocardial infarction. Cost-effectiveness of alternatives to coronary-care-unit admission. N Engl J Med 1984; 310:1301–7.
Lee TH, Rouan GW, Weisberg MC, Brand DA, Acampora D, Stasiulewicz C, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987;60:219–24.
Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 342:1163–70.
Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003;26:917–32.
Kang X, Berman DS, Lewin H, Miranda R, Erel J, Friedman JD, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 1999;137:949–57.
Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004;27:1954–61.
Mieres JH, Shaw LJ, Arai A, Budoff M, Hundley G, Flamm SD, et al. for the Cardiovascular Imaging Committee. American Heart Association-Cardiac Imaging Committee Consensus Statement: The role of cardiac imaging in the clinical evaluation of women with known or suspected coronary artery disease. Circulation 2005;111:682–96.
Mowatt G, Brazzelli M, Gemmell H, Hillis GS, Metcalfe M, Vale L; Aberdeen Technology Assessment Group. Systematic review of the prognostic effectiveness of SPECT myocardial perfusion scintigraphy in patients with suspected or known coronary artery disease and following myocardial infarction. Nucl Med Comm 2005;26:217–29.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Des Prez, R.D., Shaw, L.J., Gillespie, R.L. et al. Cost-effectiveness of myocardial perfusion imaging: A summary of the currently available literature. J Nucl Cardiol 12, 750–759 (2005). https://doi.org/10.1016/j.nuclcard.2005.10.001
Issue Date:
DOI: https://doi.org/10.1016/j.nuclcard.2005.10.001